36 results
Thumbnail

D1.270 - Irish Infant Allergy and Nutrition: A Content Analysis of Public-Facing Online Guidance

Thumbnail

D1.273 - Burden of food allergy on daily life and emotions in children and parents: Insights from the IPAA French Cohort

Thumbnail

D1.274 - Evaluating adherence to and effectiveness of food allergy advice in parents of infants under 6 months old suffering from atopic dermatitis

Thumbnail

D1.264 - A Case of Chronic Food Protein-Induced Enterocolitis Syndrome triggered by Egg Yolk via Breast Milk

Thumbnail

D1.265 - Predicting Milk Ladder Outcomes for Management of IgE-Mediated Cow’s Milk Protein Allergy: Feature Selection Using Machine Learning Methods

Thumbnail

D1.266 - Phenotypes of IgE-mediated Cow’s Milk Protein Allergy in an Irish Cohort Using Latent Class Analysis

Thumbnail

D1.267 - Clinical Features and Dairy Triggers for Cow’s Milk Allergy among 342 Chinese Children in a University-affiliated Allergy Clinic in Hong Kong

Thumbnail

D1.268 - Advancing Paediatric Egg Allergy Management via Telemedicine: Outcomes of Remote Egg Ladder Support

Thumbnail

D1.271 - Parental Vaccine Hesitancy And Immunization Practices In Children With Food Allergy

Thumbnail

D1.272 - Improving Culinary Medicine and Food Allergy Knowledge Through a STEM-Integrated Medical-Student-Led Cooking Program for Youth in New Orleans

Thumbnail

D1.275 - Pollen-Food Allergy Syndrome among Final-Year Primary School Students in the City of Olsztyn and Olsztyn County, Poland: A Questionnaire-Based Cross-Sectional Study

Thumbnail

D1.277 - Selective goat’s and sheep’s milk anaphylaxis: Advocacy for mandatory food labeling of milk origins

Thumbnail

D2.490 - Consistent efficacy of a seasonal 300IR birch pollen sublingual immunotherapy in children and adolescents during worst pollen exposure: results of the YOBI trial

Thumbnail

D2.491 - Efficacy of a 300IR birch liquid sublingual immunotherapy during the alder and hazel pollen seasons: results of the YOBI trial

Thumbnail

D2.492 - Efficacy and safety of a 300IR daily dose of a SLIT of birch pollen allergen extract in children and adolescents with allergic rhinoconjunctivitis: results from the YOBI trial

Thumbnail

D2.494 - Tralokinumab treatment in adults with atopic dermatitis who were previously treated with dupilumab: 12-months real-world data from the TRACE study

Thumbnail

D2.495 - Treatment with Izicopan (INF904), an oral anti-C5aR inhibitor improves efficacy and safety in patients with chronic spontaneous urticaria: results from a Phase 2a study

Thumbnail

D2.496 - First-in-Human Phase I Clinical Outcomes of BxC-I17e Enriched with HSP70/miR-22-3p in Atopic Dermatitis

Thumbnail

D2.497 - Oral Deucrictibant Immediate-Release Capsule for On-Demand Treatment of Hereditary Angioedema Attacks: Results of the Phase 3 RAPIDe-3 Trial

Thumbnail

D2.498 - Berotralstat Decreased HAE Attacks Treated with On-Demand Therapy or Utilizing Professional Care in Pediatric Patients Aged 2 to